Upfront Xpert MTB/RIF testing for pediatric TB – paper from Sophie Huddart

Sophie contributed to the paper “Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation“, published in PLoS One. As she puts it: “This is a deeper dive into the infant TB cases diagnosed with Xpert. Almost all were diagnosed using non-sputum samples and 5% were rif resistant. We also observed an 11% mortality in TB cases. This is certainly the largest cohort of infant TB I’ve come across and it paints a scary picture!”

Lancet Global Health: report of the HQSS Commission

The report of the HQSS Commission was published today in the Lancet GH. TB is prominently used throughout the report and you can see that by searching for tuberculosis in the PDF. Some of our team’s work is also cited. For this, we can thank Danielle and Tripti, who worked hard with the HQSS team on the TB aspects. Look for their names in the acknowledgements section! Check out also Madhu’s blog post on the subject in Nature Microbiology.

Welcome to Lena Faust

Lena is joining the Pai TB Group to do a PhD, with Madhu serving as her supervisor. Welcome Lena!

NIH award for Amrita Daftary

Congratulations to Amrita who is Co-Investigator on a new NIH R21 award: Evaluating a multimodal behavioral intervention to reduce stigma in HIV/drug resistant TB in KwaZulu-Natal, South Africa (PI: O’Donnell MR, Columbia University)!

1 38 39 40 41 42 43 44 56